Cernobbio, Italy

Enrico Baroni

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Helsinn Healthcare Sa. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Enrico Baroni. Retrieved from https://idiyas.com/inventor/enrico-baroni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Enrico Baroni

Introduction

Enrico Baroni is an accomplished inventor based in Cernobbio, Italy. With a strong focus on medical advancements, he has secured a total of four patents, showcasing his commitment to improving healthcare through innovation.

Latest Patents

Among his latest contributions, Baroni has developed medical treatments based on anamorelin. These patents describe methods of treating cancer-related conditions using anamorelin, indicating his dedication to finding solutions for serious health issues.

Career Highlights

Baroni is a key member of Helsinn Healthcare SA, where he plays a pivotal role in the development of innovative medical therapies. His work in this esteemed organization highlights his expertise in the medical field and reflects his commitment to enhancing patient care.

Collaborations

Throughout his career, Baroni has collaborated with notable colleagues, including William Mann and John Friend. These partnerships have likely facilitated the exchange of ideas and innovative approaches, further driving the advancement of medical treatments.

Conclusion

Enrico Baroni’s inventive spirit and dedication to medical research position him as a valuable asset in the ongoing fight against cancer. His contributions, particularly the patents based on anamorelin, represent significant strides in the development of effective treatment methodologies. As he continues his work at Helsinn Healthcare SA, his future innovations are eagerly anticipated.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…